158 related articles for article (PubMed ID: 32795656)
1. The combination of coffee compounds attenuates early fibrosis-associated hepatocarcinogenesis in mice: involvement of miRNA profile modulation.
Romualdo GR; Prata GB; da Silva TC; Evangelista AF; Reis RM; Vinken M; Moreno FS; Cogliati B; Barbisan LF
J Nutr Biochem; 2020 Nov; 85():108479. PubMed ID: 32795656
[TBL] [Abstract][Full Text] [Related]
2. Caffeine and Chlorogenic Acid Combination Attenuate Early-Stage Chemically Induced Colon Carcinogenesis in Mice: Involvement of oncomiR miR-21a-5p.
Bartolomeu AR; Romualdo GR; Lisón CG; Besharat ZM; Corrales JAM; Chaves MÁG; Barbisan LF
Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682971
[TBL] [Abstract][Full Text] [Related]
3. Next generation sequencing reveals microRNA isoforms in liver cirrhosis and hepatocellular carcinoma.
Wojcicka A; Swierniak M; Kornasiewicz O; Gierlikowski W; Maciag M; Kolanowska M; Kotlarek M; Gornicka B; Koperski L; Niewinski G; Krawczyk M; Jazdzewski K
Int J Biochem Cell Biol; 2014 Aug; 53():208-17. PubMed ID: 24875649
[TBL] [Abstract][Full Text] [Related]
4. β-ionone modulates the expression of miRNAs and genes involved in the metastatic phenotype of microdissected persistent preneoplastic lesions in rats submitted to hepatocarcinogenesis.
Furtado KS; de Oliveira Andrade F; Campos A; Rosim MP; Vargas-Mendez E; Henriques A; De Conti A; Scolastici C; Barbisan LF; Carvalho RF; Moreno FS
Mol Carcinog; 2017 Jan; 56(1):184-196. PubMed ID: 27061051
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of miR-483-5p/3p cooperate to inhibit mouse liver fibrosis by suppressing the TGF-β stimulated HSCs in transgenic mice.
Li F; Ma N; Zhao R; Wu G; Zhang Y; Qiao Y; Han D; Xu Y; Xiang Y; Yan B; Jin J; Lv G; Wang L; Xu C; Gao X; Luo S
J Cell Mol Med; 2014 Jun; 18(6):966-74. PubMed ID: 24801603
[TBL] [Abstract][Full Text] [Related]
6. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of microRNA-214 ameliorates hepatic fibrosis and tumor incidence in platelet-derived growth factor C transgenic mice.
Okada H; Honda M; Campbell JS; Takegoshi K; Sakai Y; Yamashita T; Shirasaki T; Takabatake R; Nakamura M; Tanaka T; Kaneko S
Cancer Sci; 2015 Sep; 106(9):1143-52. PubMed ID: 26122702
[TBL] [Abstract][Full Text] [Related]
8. Fibrosis-associated hepatocarcinogenesis revisited: Establishing standard medium-term chemically-induced male and female models.
Romualdo GR; Prata GB; da Silva TC; Fernandes AAH; Moreno FS; Cogliati B; Barbisan LF
PLoS One; 2018; 13(9):e0203879. PubMed ID: 30212575
[TBL] [Abstract][Full Text] [Related]
9. Candidate lncRNA-miRNA-mRNA network in predicting hepatocarcinogenesis with cirrhosis: an integrated bioinformatics analysis.
Zhang R; Jiang YY; Xiao K; Huang XQ; Wang J; Chen SY
J Cancer Res Clin Oncol; 2020 Jan; 146(1):87-96. PubMed ID: 31758243
[TBL] [Abstract][Full Text] [Related]
10. Molecular Pathways Leading to Induction of Cell Death and Anti-Proliferative Properties by Tacrolimus and mTOR Inhibitors in Liver Cancer Cells.
Navarro-Villarán E; de la Cruz-Ojeda P; Contreras L; González R; Negrete M; Rodríguez-Hernández MA; Marín-Gómez LM; Álamo-Martínez JM; Calvo A; Gómez-Bravo MA; de la Cruz J; Padillo J; Muntané J
Cell Physiol Biochem; 2020 May; 54(3):457-473. PubMed ID: 32369692
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D
Goto RL; Tablas MB; Prata GB; Espírito Santo SG; Fernandes AAH; Cogliati B; Barbisan LF; Romualdo GR
J Steroid Biochem Mol Biol; 2022 Jan; 215():106022. PubMed ID: 34774723
[TBL] [Abstract][Full Text] [Related]
12. Abnormal expression and mechanism of miR-330-3p/BTG1 axis in hepatocellular carcinoma.
Zhao X; Chen GQ; Cao GM
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6888-6898. PubMed ID: 31486488
[TBL] [Abstract][Full Text] [Related]
13. Activation of Nrf2 pathway and inhibition of NLRP3 inflammasome activation contribute to the protective effect of chlorogenic acid on acute liver injury.
Shi A; Shi H; Wang Y; Liu X; Cheng Y; Li H; Zhao H; Wang S; Dong L
Int Immunopharmacol; 2018 Jan; 54():125-130. PubMed ID: 29128856
[TBL] [Abstract][Full Text] [Related]
14. Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma.
Jin Y; Wong YS; Goh BKP; Chan CY; Cheow PC; Chow PKH; Lim TKH; Goh GBB; Krishnamoorthy TL; Kumar R; Ng TP; Chong SS; Tan HH; Chung AYF; Ooi LLPJ; Chang JPE; Tan CK; Lee CGL
Sci Rep; 2019 Jul; 9(1):10464. PubMed ID: 31320713
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of anthocyanin-rich peels of Myrtaceae fruits on chemically-induced liver fibrosis and carcinogenesis in mice.
Romualdo GR; de Souza IP; de Souza LV; Prata GB; Fraga-Silva TFC; Sartori A; Borguini RG; Santiago MCPA; Fernandes AAH; Cogliati B; Barbisan LF
Food Res Int; 2021 Jan; 139():109964. PubMed ID: 33509514
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-34a-5p inhibits liver fibrosis by regulating TGF-β1/Smad3 pathway in hepatic stellate cells.
Feili X; Wu S; Ye W; Tu J; Lou L
Cell Biol Int; 2018 Sep; 42(10):1370-1376. PubMed ID: 29957876
[TBL] [Abstract][Full Text] [Related]
17. Mir-452-3p: A Potential Tumor Promoter That Targets the CPEB3/EGFR Axis in Human Hepatocellular Carcinoma.
Tang H; Zhang J; Yu Z; Ye L; Li K; Ding F; Feng X; Meng W
Technol Cancer Res Treat; 2017 Dec; 16(6):1136-1149. PubMed ID: 29332449
[TBL] [Abstract][Full Text] [Related]
18. Chlorogenic acid and caffeine in combination inhibit fat accumulation by regulating hepatic lipid metabolism-related enzymes in mice.
Zheng G; Qiu Y; Zhang QF; Li D
Br J Nutr; 2014 Sep; 112(6):1034-40. PubMed ID: 25201308
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma.
Fuchs BC; Hoshida Y; Fujii T; Wei L; Yamada S; Lauwers GY; McGinn CM; DePeralta DK; Chen X; Kuroda T; Lanuti M; Schmitt AD; Gupta S; Crenshaw A; Onofrio R; Taylor B; Winckler W; Bardeesy N; Caravan P; Golub TR; Tanabe KK
Hepatology; 2014 Apr; 59(4):1577-90. PubMed ID: 24677197
[TBL] [Abstract][Full Text] [Related]
20. [MicroRNAs in hepatocarcinogenesis].
Lendvai G; Kiss A; Kovalszky I; Schaff Z
Orv Hetil; 2012 Jun; 153(25):978-89. PubMed ID: 22714032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
